Skip to main content

Table 2 Completion rates over time for HRQoL questionnaires

From: Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors: health-related quality of life among melanoma patients in a randomized controlled trial

 

FACT-M

EQ-5D-5L

Intervention group

Control group

Intervention group

Control group

n (%)

n (%)

n (%)

n (%)

Baseline

63 (94)

67 (94)

63 (94)

67 (94)

Week 24

51 (76)

53 (75)

52 (78)

54 (76)

Week 48

38 (56)

35 (49)

39 (58)

36 (51)